Skip to main content

Table 3 Events recorded in the cohort and in each of the four groups

From: Low molecular weight heparins use in pregnancy: a practice survey from Greece and a review of the literature

 

Group A N = 76

Group B N = 445

Group C N = 132

Group D N = 165

Total N = 818

p*

VTE [VTE postpartum]

3 (3.9%) [1 (1.3%)]

3 (0.7%) [3 (0.7%)]

0 [1 (0.8%)]

1 (0.6%) [5 (3.0%)]

7 (0.8%) [10 (1.2%)]

0.0008

Bleeding

1 (1.3%)

6 (1.3%)

5 (3.8%)

1 (0.6%)

13 (1.6%)

0.151

Gestational vascular complications

12 (15.8%)

37 (8.3%)

23 (17.4%)

16 (9.7%)

88 (10.8%)

0.0064

IUGR

2 (2.6%)

13 (2.9%)

8 (6.1%)

5 (3.0%)

28 (3.4%)

0.8784

Preterm Labor

7 (9.2%)

19 (9.1%)

12 (9.1%)

10 (6.1%)

48 (5.9%)

Fetal Death

1 (1.3%)

1 (0.2%)

1 (0.8%)

 

3 (0.4%)

Early pregnancy loss/abortion

1 (1.3%)

3 (0.7%)

2 (1.5%)

 

6 (0.7%)

Pre-eclampsia/eclampsia

1 (1.3%)

1 (0.2%)

 

1 (0.6%)

3 (0.4%)

  1. * p-value is for chi-square test